Comparison of Immunosorbent Assays for the Quantification of Biomarkers for Alzheimer’s Disease in Human Cerebrospinal Fluid

Pittsburgh Compound-B and Alzheimer’s Disease Biomarkers in CSF, Plasma and Urine: An Exploratory Study

(2010) M. Degerman Gunnarsson et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer’s disease

(2009) E. H. Wiig et al.   ACTA NEUROLOGICA SCANDINAVICA

Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment

(2009) Johannes Kornhuber et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

(2009) A. Petzold et al.   EXPERIMENTAL NEUROLOGY

Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers

(2009) Piotr Lewczuk et al.   JOURNAL OF NEURAL TRANSMISSION

Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding

(2009) N. Tolboom et al.   JOURNAL OF NUCLEAR MEDICINE

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

(2009) N A Verwey et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

(2008) P Lewczuk et al.   MOLECULAR PSYCHIATRY

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

(2008) Oskar Hansson et al.   NEUROBIOLOGY OF AGING